

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation via MHC class Ib (GO:0002475) | 9.96204641 |
| 2 | positive regulation of antigen processing and presentation (GO:0002579) | 7.84571098 |
| 3 | regulation of antigen processing and presentation (GO:0002577) | 6.62239976 |
| 4 | behavioral response to nicotine (GO:0035095) | 5.84531054 |
| 5 | fucose catabolic process (GO:0019317) | 4.87294875 |
| 6 | L-fucose metabolic process (GO:0042354) | 4.87294875 |
| 7 | L-fucose catabolic process (GO:0042355) | 4.87294875 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.83114806 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.83114806 |
| 10 | response to pheromone (GO:0019236) | 4.49765793 |
| 11 | regulation of memory T cell differentiation (GO:0043380) | 4.38071932 |
| 12 | monocyte chemotaxis (GO:0002548) | 4.34903574 |
| 13 | regulation of acrosome reaction (GO:0060046) | 4.12300773 |
| 14 | eosinophil chemotaxis (GO:0048245) | 4.09228590 |
| 15 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.06782646 |
| 16 | response to muramyl dipeptide (GO:0032495) | 4.00416082 |
| 17 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.00292742 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.99102241 |
| 19 | protein polyglutamylation (GO:0018095) | 3.91722381 |
| 20 | DNA deamination (GO:0045006) | 3.78806721 |
| 21 | regulation of pigment cell differentiation (GO:0050932) | 3.77394767 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.73989364 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.73989364 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 3.73989364 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.73989364 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.73989364 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.73989364 |
| 28 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.66468042 |
| 29 | cyclooxygenase pathway (GO:0019371) | 3.63417257 |
| 30 | negative regulation of mast cell activation (GO:0033004) | 3.60115352 |
| 31 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.56631909 |
| 32 | detection of light stimulus involved in visual perception (GO:0050908) | 3.56631909 |
| 33 | positive regulation of defense response to virus by host (GO:0002230) | 3.56445757 |
| 34 | eosinophil migration (GO:0072677) | 3.55964069 |
| 35 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.55412644 |
| 36 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.54377710 |
| 37 | regulation of cilium movement (GO:0003352) | 3.53686239 |
| 38 | kynurenine metabolic process (GO:0070189) | 3.51114315 |
| 39 | nonmotile primary cilium assembly (GO:0035058) | 3.46526439 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.44324840 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.44324840 |
| 42 | tryptophan catabolic process (GO:0006569) | 3.44324840 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.43741736 |
| 44 | indolalkylamine metabolic process (GO:0006586) | 3.41329748 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.39743428 |
| 46 | phagocytosis, engulfment (GO:0006911) | 3.36788751 |
| 47 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.34338703 |
| 48 | respiratory burst (GO:0045730) | 3.33812009 |
| 49 | opioid receptor signaling pathway (GO:0038003) | 3.31211748 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.29738405 |
| 51 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.27729917 |
| 52 | axoneme assembly (GO:0035082) | 3.26196360 |
| 53 | negative regulation of granulocyte differentiation (GO:0030853) | 3.23071062 |
| 54 | neural tube formation (GO:0001841) | 3.17261385 |
| 55 | epithelial cilium movement (GO:0003351) | 3.13802587 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 3.12737897 |
| 57 | neutrophil activation (GO:0042119) | 3.12728691 |
| 58 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.10202272 |
| 59 | cellular extravasation (GO:0045123) | 3.09377417 |
| 60 | regulation of action potential (GO:0098900) | 3.09259889 |
| 61 | G-protein coupled receptor internalization (GO:0002031) | 3.07748906 |
| 62 | lipoxygenase pathway (GO:0019372) | 3.07480138 |
| 63 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.06607485 |
| 64 | rRNA catabolic process (GO:0016075) | 3.05842250 |
| 65 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.01107097 |
| 66 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.99830006 |
| 67 | regulation of B cell differentiation (GO:0045577) | 2.98905966 |
| 68 | multicellular organism reproduction (GO:0032504) | 2.98861773 |
| 69 | melanocyte differentiation (GO:0030318) | 2.97612124 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97302552 |
| 71 | cilium morphogenesis (GO:0060271) | 2.94924767 |
| 72 | granulocyte activation (GO:0036230) | 2.94666133 |
| 73 | prostanoid metabolic process (GO:0006692) | 2.93950066 |
| 74 | prostaglandin metabolic process (GO:0006693) | 2.93950066 |
| 75 | platelet dense granule organization (GO:0060155) | 2.92828974 |
| 76 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92624668 |
| 77 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.92440076 |
| 78 | plasma membrane fusion (GO:0045026) | 2.89859820 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.89014214 |
| 80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86970970 |
| 81 | purinergic receptor signaling pathway (GO:0035587) | 2.86915657 |
| 82 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.86336853 |
| 83 | piRNA metabolic process (GO:0034587) | 2.85686450 |
| 84 | kidney morphogenesis (GO:0060993) | 2.85626546 |
| 85 | retinal cone cell development (GO:0046549) | 2.85019835 |
| 86 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.84606794 |
| 87 | regulation of mesoderm development (GO:2000380) | 2.84596825 |
| 88 | tryptophan metabolic process (GO:0006568) | 2.82271449 |
| 89 | response to peptidoglycan (GO:0032494) | 2.81158069 |
| 90 | ketone body metabolic process (GO:1902224) | 2.78940591 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78863085 |
| 92 | nucleobase catabolic process (GO:0046113) | 2.78035008 |
| 93 | protein localization to cilium (GO:0061512) | 2.77805833 |
| 94 | regulation of hexokinase activity (GO:1903299) | 2.76808450 |
| 95 | regulation of glucokinase activity (GO:0033131) | 2.76808450 |
| 96 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.76250074 |
| 97 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.74308627 |
| 98 | neuronal action potential (GO:0019228) | 2.72439354 |
| 99 | regulation of microtubule-based movement (GO:0060632) | 2.72356513 |
| 100 | protein complex biogenesis (GO:0070271) | 2.72156556 |
| 101 | gamma-aminobutyric acid transport (GO:0015812) | 2.71859483 |
| 102 | cellular biogenic amine catabolic process (GO:0042402) | 2.70431008 |
| 103 | amine catabolic process (GO:0009310) | 2.70431008 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.70209680 |
| 105 | respiratory chain complex IV assembly (GO:0008535) | 2.70142774 |
| 106 | negative regulation of telomere maintenance (GO:0032205) | 2.69776401 |
| 107 | photoreceptor cell maintenance (GO:0045494) | 2.69590484 |
| 108 | reciprocal DNA recombination (GO:0035825) | 2.68561858 |
| 109 | reciprocal meiotic recombination (GO:0007131) | 2.68561858 |
| 110 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.68504223 |
| 111 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.68504223 |
| 112 | NADH dehydrogenase complex assembly (GO:0010257) | 2.68504223 |
| 113 | behavioral response to ethanol (GO:0048149) | 2.67353467 |
| 114 | complement activation, alternative pathway (GO:0006957) | 2.66327887 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 2.65977570 |
| 116 | response to host immune response (GO:0052572) | 2.65170180 |
| 117 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65170180 |
| 118 | protein K11-linked deubiquitination (GO:0035871) | 2.63401794 |
| 119 | exogenous drug catabolic process (GO:0042738) | 2.63267504 |
| 120 | positive regulation of cell fate commitment (GO:0010455) | 2.62558762 |
| 121 | regulation of tolerance induction (GO:0002643) | 2.61254175 |
| 122 | tolerance induction (GO:0002507) | 2.61055624 |
| 123 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60321766 |
| 124 | positive regulation of type 2 immune response (GO:0002830) | 2.59896239 |
| 125 | ubiquinone biosynthetic process (GO:0006744) | 2.59124811 |
| 126 | pigment cell differentiation (GO:0050931) | 2.59080307 |
| 127 | synaptic transmission, cholinergic (GO:0007271) | 2.58956570 |
| 128 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.58386351 |
| 129 | indole-containing compound metabolic process (GO:0042430) | 2.58219400 |
| 130 | positive thymic T cell selection (GO:0045059) | 2.57684357 |
| 131 | protein-cofactor linkage (GO:0018065) | 2.57623762 |
| 132 | cellular response to zinc ion (GO:0071294) | 2.57188779 |
| 133 | microglial cell activation (GO:0001774) | 2.56715376 |
| 134 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.56520535 |
| 135 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.56331164 |
| 136 | drug catabolic process (GO:0042737) | 2.56215560 |
| 137 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.55193168 |
| 138 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.55193168 |
| 139 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.55193168 |
| 140 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.54329436 |
| 141 | replication fork processing (GO:0031297) | 2.53735863 |
| 142 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52936846 |
| 143 | sulfation (GO:0051923) | 2.52112320 |
| 144 | histone H3-K4 trimethylation (GO:0080182) | 2.51716789 |
| 145 | oxidative demethylation (GO:0070989) | 2.51706359 |
| 146 | cilium movement (GO:0003341) | 2.51656190 |
| 147 | negative regulation of type 2 immune response (GO:0002829) | 2.50800270 |
| 148 | positive regulation of prostaglandin secretion (GO:0032308) | 2.50558334 |
| 149 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.48491688 |
| 150 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.48218687 |
| 151 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.47814922 |
| 152 | cornea development in camera-type eye (GO:0061303) | 2.46143638 |
| 153 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.45532494 |
| 154 | fucosylation (GO:0036065) | 2.44971145 |
| 155 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.44841974 |
| 156 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.43544172 |
| 157 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.42869120 |
| 158 | cilium organization (GO:0044782) | 2.42828752 |
| 159 | reflex (GO:0060004) | 2.42580962 |
| 160 | S-adenosylmethionine metabolic process (GO:0046500) | 2.41794197 |
| 161 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.41700817 |
| 162 | meiotic chromosome segregation (GO:0045132) | 2.41657802 |
| 163 | transmission of nerve impulse (GO:0019226) | 2.41565441 |
| 164 | positive regulation of fatty acid transport (GO:2000193) | 2.40255504 |
| 165 | thyroid hormone metabolic process (GO:0042403) | 2.40150415 |
| 166 | adaptation of signaling pathway (GO:0023058) | 2.39893534 |
| 167 | photoreceptor cell development (GO:0042461) | 2.38843174 |
| 168 | negative regulation of interleukin-12 production (GO:0032695) | 2.37951804 |
| 169 | ncRNA catabolic process (GO:0034661) | 2.37871539 |
| 170 | membrane invagination (GO:0010324) | 2.37233277 |
| 171 | regulation of type 2 immune response (GO:0002828) | 2.36099136 |
| 172 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.36083417 |
| 173 | linoleic acid metabolic process (GO:0043651) | 2.32894326 |
| 174 | myeloid dendritic cell differentiation (GO:0043011) | 2.32453011 |
| 175 | glycerophospholipid catabolic process (GO:0046475) | 2.32265525 |
| 176 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.31709656 |
| 177 | positive regulation of interleukin-12 production (GO:0032735) | 2.29181897 |
| 178 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.28495061 |
| 179 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.27727194 |
| 180 | positive regulation of response to biotic stimulus (GO:0002833) | 2.27623678 |
| 181 | arachidonic acid metabolic process (GO:0019369) | 2.27393216 |
| 182 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.26081943 |
| 183 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.25783748 |
| 184 | neuroepithelial cell differentiation (GO:0060563) | 2.25379582 |
| 185 | myeloid leukocyte migration (GO:0097529) | 2.25322884 |
| 186 | T cell homeostasis (GO:0043029) | 2.22310374 |
| 187 | GPI anchor metabolic process (GO:0006505) | 2.22294958 |
| 188 | macrophage chemotaxis (GO:0048246) | 2.22070161 |
| 189 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.21964617 |
| 190 | positive regulation of response to oxidative stress (GO:1902884) | 2.21342160 |
| 191 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.21342160 |
| 192 | positive regulation of lymphocyte migration (GO:2000403) | 2.20982677 |
| 193 | regulation of granulocyte differentiation (GO:0030852) | 2.19950166 |
| 194 | positive T cell selection (GO:0043368) | 2.19723325 |
| 195 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 11.7153974 |
| 196 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 11.7153974 |
| 197 | antigen processing and presentation of endogenous antigen (GO:0019883) | 11.5784487 |
| 198 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 11.1373514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.21788310 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.85453479 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.72184285 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.82196754 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.42406099 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.31494599 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.85291570 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.61828879 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.51934639 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.49675357 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34644220 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31361517 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16302610 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09072112 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08900138 |
| 16 | * EWS_26573619_Chip-Seq_HEK293_Human | 2.06128344 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99696681 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.95085046 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95059033 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.94474219 |
| 21 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.91746428 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.78418284 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76970970 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76804804 |
| 25 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.76605432 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76484981 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74490374 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73402853 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72134078 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.71350402 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64998959 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.62843831 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62391144 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62280633 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56507480 |
| 36 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.55081431 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54684564 |
| 38 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50969839 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49459950 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49451281 |
| 41 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.49183433 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48750565 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44499966 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43749719 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43629496 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42806698 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42806698 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41169818 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41147831 |
| 50 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40715117 |
| 51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.40106229 |
| 52 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.40106229 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40000009 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.39729160 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39466446 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37618319 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37471779 |
| 58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.37034708 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36082231 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36082231 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.36051049 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34974591 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34469082 |
| 64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.33885915 |
| 65 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.33529628 |
| 66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32929328 |
| 67 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32929328 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32596113 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32492641 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32079252 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31013949 |
| 72 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28338067 |
| 73 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27049739 |
| 74 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.26641701 |
| 75 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25462332 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25462332 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25049944 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24649612 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.24233551 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24083820 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23243553 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23200744 |
| 83 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22995754 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22927709 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22909813 |
| 86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22853193 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22767537 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22351300 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21788172 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21495831 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20199778 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19753108 |
| 93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19559961 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18650745 |
| 95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18038832 |
| 96 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17916421 |
| 97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17387289 |
| 98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17014826 |
| 99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16472035 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15940109 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15697627 |
| 102 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15085512 |
| 103 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.15067738 |
| 104 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15063869 |
| 105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14315596 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14031474 |
| 107 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12812495 |
| 108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12097209 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10167505 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10041504 |
| 111 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10024862 |
| 112 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09160356 |
| 113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09033935 |
| 114 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07479124 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07263903 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06993363 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06405550 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05622223 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05516483 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05186909 |
| 121 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02454312 |
| 122 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01775464 |
| 123 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01451489 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00264092 |
| 125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00196962 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99792451 |
| 127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99393666 |
| 128 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98849242 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98715043 |
| 130 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98028675 |
| 131 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97863546 |
| 132 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97500943 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97317342 |
| 134 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97163826 |
| 135 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96173431 |
| 136 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96120899 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95957577 |
| 138 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94865234 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94648957 |
| 140 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94129748 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93365715 |
| 142 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93260219 |
| 143 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93188549 |
| 144 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92974567 |
| 145 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.92446547 |
| 146 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92126127 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91806250 |
| 148 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89097219 |
| 149 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89028991 |
| 150 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88497794 |
| 151 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88137098 |
| 152 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87029350 |
| 153 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86427647 |
| 154 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86240595 |
| 155 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86226641 |
| 156 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85916486 |
| 157 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85627151 |
| 158 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.85197991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.40035630 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.96350349 |
| 3 | MP0003303_peritoneal_inflammation | 3.68686951 |
| 4 | MP0003195_calcinosis | 3.65279513 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.02315464 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.89772985 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.74928024 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.53689455 |
| 9 | MP0003436_decreased_susceptibility_to | 2.52725839 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.48232562 |
| 11 | MP0002254_reproductive_system_inflammat | 2.43225969 |
| 12 | MP0002419_abnormal_innate_immunity | 2.39158546 |
| 13 | MP0000015_abnormal_ear_pigmentation | 2.29965880 |
| 14 | MP0001790_abnormal_immune_system | 2.29722835 |
| 15 | MP0005387_immune_system_phenotype | 2.29722835 |
| 16 | MP0004510_myositis | 2.26810754 |
| 17 | MP0002102_abnormal_ear_morphology | 2.21147869 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.20512777 |
| 19 | MP0008004_abnormal_stomach_pH | 2.19711934 |
| 20 | MP0002653_abnormal_ependyma_morphology | 2.19559264 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.17956633 |
| 22 | MP0003880_abnormal_central_pattern | 2.17799684 |
| 23 | MP0008872_abnormal_physiological_respon | 2.17637672 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.08998676 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.05951017 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.04595431 |
| 27 | MP0000685_abnormal_immune_system | 2.03046090 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02405318 |
| 29 | MP0004043_abnormal_pH_regulation | 2.01802633 |
| 30 | MP0005671_abnormal_response_to | 1.94682311 |
| 31 | MP0003646_muscle_fatigue | 1.91449708 |
| 32 | MP0001986_abnormal_taste_sensitivity | 1.88548127 |
| 33 | MP0003136_yellow_coat_color | 1.87136921 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.82672377 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.77450284 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.75371766 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.74970838 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.74892785 |
| 39 | MP0005409_darkened_coat_color | 1.73552713 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.73276831 |
| 41 | MP0001800_abnormal_humoral_immune | 1.73126021 |
| 42 | MP0001853_heart_inflammation | 1.70220074 |
| 43 | MP0005253_abnormal_eye_physiology | 1.66952917 |
| 44 | MP0002938_white_spotting | 1.66240240 |
| 45 | MP0005025_abnormal_response_to | 1.65248287 |
| 46 | MP0002272_abnormal_nervous_system | 1.64951022 |
| 47 | MP0002723_abnormal_immune_serum | 1.62643412 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.59623366 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.57697013 |
| 50 | MP0000371_diluted_coat_color | 1.57659017 |
| 51 | MP0003866_abnormal_defecation | 1.53126652 |
| 52 | MP0006276_abnormal_autonomic_nervous | 1.50914153 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.50612428 |
| 54 | MP0001819_abnormal_immune_cell | 1.50315586 |
| 55 | MP0005310_abnormal_salivary_gland | 1.50199714 |
| 56 | MP0008874_decreased_physiological_sensi | 1.47037502 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.46451804 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.46029860 |
| 59 | MP0009785_altered_susceptibility_to | 1.44964398 |
| 60 | MP0002163_abnormal_gland_morphology | 1.43689573 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.41625217 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.41055945 |
| 63 | MP0003724_increased_susceptibility_to | 1.40600780 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.40142585 |
| 65 | MP0009046_muscle_twitch | 1.40005535 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.39595335 |
| 67 | MP0002736_abnormal_nociception_after | 1.39049938 |
| 68 | MP0009379_abnormal_foot_pigmentation | 1.38356539 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.37833961 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.33562076 |
| 71 | MP0004133_heterotaxia | 1.32728798 |
| 72 | MP0005451_abnormal_body_composition | 1.32622434 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.32281675 |
| 74 | MP0003787_abnormal_imprinting | 1.31584391 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.30799943 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 1.30724726 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.29645864 |
| 78 | MP0003011_delayed_dark_adaptation | 1.29263755 |
| 79 | MP0002075_abnormal_coat/hair_pigmentati | 1.28907376 |
| 80 | MP0000566_synostosis | 1.27256983 |
| 81 | MP0002557_abnormal_social/conspecific_i | 1.24409494 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.24302924 |
| 83 | MP0001186_pigmentation_phenotype | 1.21909913 |
| 84 | MP0001299_abnormal_eye_distance/ | 1.21672183 |
| 85 | MP0001529_abnormal_vocalization | 1.20909769 |
| 86 | MP0003045_fibrosis | 1.20741155 |
| 87 | MP0004742_abnormal_vestibular_system | 1.18759308 |
| 88 | MP0003075_altered_response_to | 1.17918368 |
| 89 | MP0004924_abnormal_behavior | 1.17908651 |
| 90 | MP0005386_behavior/neurological_phenoty | 1.17908651 |
| 91 | MP0001984_abnormal_olfaction | 1.16995440 |
| 92 | MP0008775_abnormal_heart_ventricle | 1.16910190 |
| 93 | MP0001440_abnormal_grooming_behavior | 1.16262028 |
| 94 | MP0002735_abnormal_chemical_nociception | 1.14833989 |
| 95 | MP0001188_hyperpigmentation | 1.14154583 |
| 96 | MP0005171_absent_coat_pigmentation | 1.13763031 |
| 97 | MP0003252_abnormal_bile_duct | 1.11690359 |
| 98 | MP0003121_genomic_imprinting | 1.10272680 |
| 99 | MP0010386_abnormal_urinary_bladder | 1.10012122 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 1.08792584 |
| 101 | MP0002063_abnormal_learning/memory/cond | 1.05311235 |
| 102 | MP0009763_increased_sensitivity_to | 1.05129594 |
| 103 | MP0005365_abnormal_bile_salt | 1.04276497 |
| 104 | MP0002733_abnormal_thermal_nociception | 1.04137957 |
| 105 | MP0002405_respiratory_system_inflammati | 1.04005071 |
| 106 | MP0001845_abnormal_inflammatory_respons | 1.03406343 |
| 107 | MP0005423_abnormal_somatic_nervous | 1.02754534 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 1.02588609 |
| 109 | MP0004145_abnormal_muscle_electrophysio | 1.02493638 |
| 110 | MP0005389_reproductive_system_phenotype | 1.01797267 |
| 111 | MP0002928_abnormal_bile_duct | 1.01464709 |
| 112 | MP0009764_decreased_sensitivity_to | 1.00471006 |
| 113 | MP0005195_abnormal_posterior_eye | 0.99232566 |
| 114 | MP0005377_hearing/vestibular/ear_phenot | 0.99205975 |
| 115 | MP0003878_abnormal_ear_physiology | 0.99205975 |
| 116 | MP0005410_abnormal_fertilization | 0.98847273 |
| 117 | MP0004142_abnormal_muscle_tone | 0.93785667 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.93534044 |
| 119 | MP0001905_abnormal_dopamine_level | 0.93189071 |
| 120 | MP0001919_abnormal_reproductive_system | 0.93074204 |
| 121 | MP0001486_abnormal_startle_reflex | 0.92960407 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.91439118 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.89830519 |
| 124 | MP0000778_abnormal_nervous_system | 0.88183138 |
| 125 | MP0002277_abnormal_respiratory_mucosa | 0.87717576 |
| 126 | MP0009745_abnormal_behavioral_response | 0.86917048 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.86652357 |
| 128 | MP0000343_altered_response_to | 0.85566750 |
| 129 | MP0000716_abnormal_immune_system | 0.85423322 |
| 130 | MP0008961_abnormal_basal_metabolism | 0.84905683 |
| 131 | MP0004134_abnormal_chest_morphology | 0.84271644 |
| 132 | MP0005085_abnormal_gallbladder_physiolo | 0.84137827 |
| 133 | MP0002396_abnormal_hematopoietic_system | 0.84135313 |
| 134 | MP0003938_abnormal_ear_development | 0.83103336 |
| 135 | MP0004147_increased_porphyrin_level | 0.82687009 |
| 136 | MP0010329_abnormal_lipoprotein_level | 0.82101309 |
| 137 | MP0003890_abnormal_embryonic-extraembry | 0.81890836 |
| 138 | MP0001873_stomach_inflammation | 0.81759196 |
| 139 | MP0000026_abnormal_inner_ear | 0.81725680 |
| 140 | MP0002160_abnormal_reproductive_system | 0.81695062 |
| 141 | MP0004885_abnormal_endolymph | 0.80923858 |
| 142 | MP0008469_abnormal_protein_level | 0.80886916 |
| 143 | MP0003091_abnormal_cell_migration | 0.80392472 |
| 144 | MP0002229_neurodegeneration | 0.79625133 |
| 145 | MP0002751_abnormal_autonomic_nervous | 0.78637702 |
| 146 | MP0005390_skeleton_phenotype | 0.78606928 |
| 147 | MP0001177_atelectasis | 0.78306348 |
| 148 | MP0002572_abnormal_emotion/affect_behav | 0.77635627 |
| 149 | MP0004859_abnormal_synaptic_plasticity | 0.77406363 |
| 150 | MP0004215_abnormal_myocardial_fiber | 0.77163468 |
| 151 | MP0000579_abnormal_nail_morphology | 0.76929278 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.76623506 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.76483340 |
| 154 | MP0002234_abnormal_pharynx_morphology | 0.74776430 |
| 155 | MP0002064_seizures | 0.73020849 |
| 156 | MP0003690_abnormal_glial_cell | 0.72978478 |
| 157 | MP0009333_abnormal_splenocyte_physiolog | 0.72561740 |
| 158 | MP0003828_pulmonary_edema | 0.69248558 |
| 159 | MP0000383_abnormal_hair_follicle | 0.68733697 |
| 160 | MP0003635_abnormal_synaptic_transmissio | 0.68551921 |
| 161 | MP0001970_abnormal_pain_threshold | 0.68393284 |
| 162 | MP0004858_abnormal_nervous_system | 0.66734607 |
| 163 | MP0002398_abnormal_bone_marrow | 0.66445165 |
| 164 | MP0000427_abnormal_hair_cycle | 0.66094754 |
| 165 | MP0002933_joint_inflammation | 0.65542146 |
| 166 | MP0001963_abnormal_hearing_physiology | 0.65423324 |
| 167 | MP0000920_abnormal_myelination | 0.64829485 |
| 168 | MP0002067_abnormal_sensory_capabilities | 0.64776427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Generalized hypopigmentation of hair (HP:0011358) | 5.55290489 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.16835069 |
| 3 | Duplicated collecting system (HP:0000081) | 4.61903376 |
| 4 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.51791912 |
| 5 | Pancreatic cysts (HP:0001737) | 4.45516333 |
| 6 | Congenital stationary night blindness (HP:0007642) | 4.16072328 |
| 7 | Abnormality of the renal collecting system (HP:0004742) | 4.11824735 |
| 8 | Abnormality of midbrain morphology (HP:0002418) | 4.07245214 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 4.07245214 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.05788131 |
| 11 | Chromsome breakage (HP:0040012) | 4.02149760 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.85922796 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.80021079 |
| 14 | Thyroid-stimulating hormone excess (HP:0002925) | 3.70013327 |
| 15 | True hermaphroditism (HP:0010459) | 3.66772032 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.65261569 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.65261569 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.58234289 |
| 19 | Colitis (HP:0002583) | 3.47592007 |
| 20 | Generalized hypopigmentation (HP:0007513) | 3.47293236 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41768714 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.41695225 |
| 23 | Nephronophthisis (HP:0000090) | 3.40646216 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 3.34859439 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.32312743 |
| 26 | Ocular albinism (HP:0001107) | 3.30462510 |
| 27 | Gingivitis (HP:0000230) | 3.19371776 |
| 28 | Myocardial infarction (HP:0001658) | 3.16693255 |
| 29 | Abolished electroretinogram (ERG) (HP:0000550) | 3.12897305 |
| 30 | Abnormality of the renal medulla (HP:0100957) | 3.04844671 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01697798 |
| 32 | Obstructive lung disease (HP:0006536) | 3.01697798 |
| 33 | Recurrent skin infections (HP:0001581) | 3.01587596 |
| 34 | Periodontitis (HP:0000704) | 2.99113763 |
| 35 | Recurrent viral infections (HP:0004429) | 2.98058350 |
| 36 | Attenuation of retinal blood vessels (HP:0007843) | 2.95540803 |
| 37 | Choroideremia (HP:0001139) | 2.94040628 |
| 38 | Progressive inability to walk (HP:0002505) | 2.93712132 |
| 39 | Tinnitus (HP:0000360) | 2.92938012 |
| 40 | Iris hypopigmentation (HP:0007730) | 2.90291272 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.89095881 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.88397264 |
| 43 | Tubular atrophy (HP:0000092) | 2.86387405 |
| 44 | Chronic otitis media (HP:0000389) | 2.86001893 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.84733301 |
| 46 | Type II lissencephaly (HP:0007260) | 2.83483082 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.79925820 |
| 48 | Hyperalaninemia (HP:0003348) | 2.79925820 |
| 49 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.79925820 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.74059052 |
| 51 | Loss of speech (HP:0002371) | 2.69290747 |
| 52 | Abnormality of DNA repair (HP:0003254) | 2.68658435 |
| 53 | Inability to walk (HP:0002540) | 2.68491000 |
| 54 | Abnormality of complement system (HP:0005339) | 2.67459881 |
| 55 | Tubulointerstitial fibrosis (HP:0005576) | 2.66409951 |
| 56 | Progressive visual loss (HP:0000529) | 2.65577958 |
| 57 | Cystic liver disease (HP:0006706) | 2.64393865 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.62997410 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.62994261 |
| 60 | Abnormal drinking behavior (HP:0030082) | 2.62218152 |
| 61 | Polydipsia (HP:0001959) | 2.62218152 |
| 62 | Complement deficiency (HP:0004431) | 2.61999444 |
| 63 | Chronic hepatic failure (HP:0100626) | 2.61077901 |
| 64 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.56794226 |
| 65 | Optic neuritis (HP:0100653) | 2.54865418 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.54865418 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.54838213 |
| 68 | Obstructive sleep apnea (HP:0002870) | 2.49757015 |
| 69 | Pendular nystagmus (HP:0012043) | 2.41229381 |
| 70 | Abnormality of the fovea (HP:0000493) | 2.39338002 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.37309045 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35024744 |
| 73 | Renal cortical cysts (HP:0000803) | 2.33744592 |
| 74 | Increased corneal curvature (HP:0100692) | 2.33219772 |
| 75 | Keratoconus (HP:0000563) | 2.33219772 |
| 76 | Viral hepatitis (HP:0006562) | 2.31253122 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.30700979 |
| 78 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.29206916 |
| 79 | Villous atrophy (HP:0011473) | 2.29206916 |
| 80 | Sclerocornea (HP:0000647) | 2.28957124 |
| 81 | Febrile seizures (HP:0002373) | 2.28624767 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.28380999 |
| 83 | Broad-based gait (HP:0002136) | 2.28192385 |
| 84 | Reticulocytopenia (HP:0001896) | 2.27729205 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.25693978 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.25693978 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.25693978 |
| 88 | Gaze-evoked nystagmus (HP:0000640) | 2.25531727 |
| 89 | Glomerulonephritis (HP:0000099) | 2.23660985 |
| 90 | 3-Methylglutaconic aciduria (HP:0003535) | 2.22831849 |
| 91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.21872733 |
| 92 | Lissencephaly (HP:0001339) | 2.21779810 |
| 93 | Large for gestational age (HP:0001520) | 2.21660345 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.21130662 |
| 95 | Polyuria (HP:0000103) | 2.18570427 |
| 96 | Hydroxyprolinuria (HP:0003080) | 2.16418686 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 2.16418686 |
| 98 | Gait imbalance (HP:0002141) | 2.14977198 |
| 99 | Congenital hepatic fibrosis (HP:0002612) | 2.14816751 |
| 100 | Anencephaly (HP:0002323) | 2.14011026 |
| 101 | Increased cerebral lipofuscin (HP:0011813) | 2.12506736 |
| 102 | Joint hemorrhage (HP:0005261) | 2.10747476 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 2.10640932 |
| 104 | Hypoplasia of the fovea (HP:0007750) | 2.09806582 |
| 105 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.09806582 |
| 106 | Intestinal atresia (HP:0011100) | 2.09492916 |
| 107 | Congenital, generalized hypertrichosis (HP:0004540) | 2.09156802 |
| 108 | Congenital primary aphakia (HP:0007707) | 2.08851596 |
| 109 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.07595166 |
| 110 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05036237 |
| 111 | Retinal atrophy (HP:0001105) | 2.04849162 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03770387 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03770387 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03770387 |
| 115 | Clumsiness (HP:0002312) | 2.01938736 |
| 116 | Cerebellar dysplasia (HP:0007033) | 2.01214093 |
| 117 | Acrocyanosis (HP:0001063) | 2.01083387 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00512638 |
| 119 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.00078947 |
| 120 | Progressive cerebellar ataxia (HP:0002073) | 1.99893959 |
| 121 | Decreased central vision (HP:0007663) | 1.99358821 |
| 122 | Pachygyria (HP:0001302) | 1.99193898 |
| 123 | White forelock (HP:0002211) | 1.98751164 |
| 124 | Keratoconjunctivitis (HP:0001096) | 1.98333192 |
| 125 | Cheilitis (HP:0100825) | 1.98100746 |
| 126 | Gingival bleeding (HP:0000225) | 1.98037224 |
| 127 | Hyperphosphatemia (HP:0002905) | 1.97621575 |
| 128 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.97115581 |
| 129 | Facial diplegia (HP:0001349) | 1.96125643 |
| 130 | Orchitis (HP:0100796) | 1.95831779 |
| 131 | Bile duct proliferation (HP:0001408) | 1.94548905 |
| 132 | Abnormal biliary tract physiology (HP:0012439) | 1.94548905 |
| 133 | Concave nail (HP:0001598) | 1.93792576 |
| 134 | Duplication of thumb phalanx (HP:0009942) | 1.92915830 |
| 135 | Distal lower limb muscle weakness (HP:0009053) | 1.92616027 |
| 136 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.91744141 |
| 137 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.91272324 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 1.91272324 |
| 139 | Absent frontal sinuses (HP:0002688) | 1.91069572 |
| 140 | Stomach cancer (HP:0012126) | 1.89328116 |
| 141 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.88311296 |
| 142 | Absent speech (HP:0001344) | 1.87136340 |
| 143 | Amyloidosis (HP:0011034) | 1.87094798 |
| 144 | Parakeratosis (HP:0001036) | 1.85024819 |
| 145 | Optic disc pallor (HP:0000543) | 1.84555313 |
| 146 | Agnosia (HP:0010524) | 1.84320913 |
| 147 | Prolonged bleeding time (HP:0003010) | 1.84022585 |
| 148 | Male pseudohermaphroditism (HP:0000037) | 1.83204371 |
| 149 | Chorioretinal atrophy (HP:0000533) | 1.82284596 |
| 150 | Asplenia (HP:0001746) | 1.81947390 |
| 151 | Genital tract atresia (HP:0001827) | 1.81367336 |
| 152 | Furrowed tongue (HP:0000221) | 1.80094486 |
| 153 | Metabolic alkalosis (HP:0200114) | 1.79578510 |
| 154 | Bilateral microphthalmos (HP:0007633) | 1.79572543 |
| 155 | Vaginal atresia (HP:0000148) | 1.79502738 |
| 156 | Widely spaced teeth (HP:0000687) | 1.79177941 |
| 157 | Optic nerve hypoplasia (HP:0000609) | 1.78814483 |
| 158 | Patellar aplasia (HP:0006443) | 1.78734364 |
| 159 | Basal ganglia calcification (HP:0002135) | 1.78214382 |
| 160 | Hyperventilation (HP:0002883) | 1.77956371 |
| 161 | Morphological abnormality of the middle ear (HP:0008609) | 1.77703884 |
| 162 | Mitochondrial inheritance (HP:0001427) | 1.77545451 |
| 163 | Fair hair (HP:0002286) | 1.77496908 |
| 164 | Deformed sella turcica (HP:0002681) | 1.77355238 |
| 165 | Protruding tongue (HP:0010808) | 1.77334214 |
| 166 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.77195572 |
| 167 | Disproportionate short-trunk short stature (HP:0003521) | 1.75790529 |
| 168 | Hypothermia (HP:0002045) | 1.75448269 |
| 169 | Nephritis (HP:0000123) | 1.75364092 |
| 170 | Increased CSF lactate (HP:0002490) | 1.75344989 |
| 171 | Macular degeneration (HP:0000608) | 1.74022469 |
| 172 | Menorrhagia (HP:0000132) | 1.73556382 |
| 173 | Postaxial foot polydactyly (HP:0001830) | 1.73445421 |
| 174 | Adactyly (HP:0009776) | 1.72224545 |
| 175 | Abnormality of the labia minora (HP:0012880) | 1.72172178 |
| 176 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71973269 |
| 177 | Agitation (HP:0000713) | 1.71969408 |
| 178 | Epistaxis (HP:0000421) | 1.71855762 |
| 179 | IgG deficiency (HP:0004315) | 1.70307964 |
| 180 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70123686 |
| 181 | Mucopolysacchariduria (HP:0008155) | 1.70123686 |
| 182 | Hypopigmentation of the fundus (HP:0007894) | 1.69484565 |
| 183 | Abnormality of the pons (HP:0007361) | 1.69217020 |
| 184 | Abnormal urine output (HP:0012590) | 1.69119706 |
| 185 | Meningitis (HP:0001287) | 1.69099629 |
| 186 | Long nose (HP:0003189) | 1.68087583 |
| 187 | Osteomalacia (HP:0002749) | 1.68085204 |
| 188 | Myositis (HP:0100614) | 1.67270083 |
| 189 | Distal lower limb amyotrophy (HP:0008944) | 1.66657871 |
| 190 | Hemiparesis (HP:0001269) | 1.66130619 |
| 191 | 11 pairs of ribs (HP:0000878) | 1.65929631 |
| 192 | Ectopic kidney (HP:0000086) | 1.65929501 |
| 193 | Sensory axonal neuropathy (HP:0003390) | 1.64820697 |
| 194 | Abnormality of the lumbar spine (HP:0100712) | 1.63786256 |
| 195 | Recurrent lower respiratory tract infections (HP:0002783) | 1.63548176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.52114191 |
| 2 | MAP3K6 | 4.11166665 |
| 3 | ACVR1B | 3.19189987 |
| 4 | MAP4K2 | 2.91973973 |
| 5 | MAP3K14 | 2.85756094 |
| 6 | BMPR1B | 2.84838373 |
| 7 | RIPK4 | 2.64822915 |
| 8 | WNK3 | 2.60388791 |
| 9 | DMPK | 2.55823977 |
| 10 | WNK4 | 2.55188956 |
| 11 | TLK1 | 2.47729908 |
| 12 | MAP2K3 | 2.45011485 |
| 13 | NUAK1 | 2.38450994 |
| 14 | IRAK4 | 2.28197307 |
| 15 | CAMKK2 | 2.04720911 |
| 16 | FGR | 1.96286838 |
| 17 | OXSR1 | 1.95720200 |
| 18 | TAOK3 | 1.94851443 |
| 19 | FES | 1.90861857 |
| 20 | STK39 | 1.89527124 |
| 21 | SIK2 | 1.87206422 |
| 22 | MAPK13 | 1.85474288 |
| 23 | CSF1R | 1.83200856 |
| 24 | TXK | 1.79894528 |
| 25 | TRIM28 | 1.79016677 |
| 26 | PINK1 | 1.76599315 |
| 27 | EPHA3 | 1.60451947 |
| 28 | MAP4K1 | 1.58098968 |
| 29 | PRPF4B | 1.57764612 |
| 30 | CASK | 1.52348519 |
| 31 | JAK3 | 1.45986183 |
| 32 | RPS6KA4 | 1.43108523 |
| 33 | FRK | 1.43094649 |
| 34 | DAPK2 | 1.41797846 |
| 35 | MAP2K4 | 1.40119877 |
| 36 | KIT | 1.39394934 |
| 37 | ADRBK2 | 1.33885680 |
| 38 | IKBKB | 1.32810893 |
| 39 | NTRK3 | 1.31173412 |
| 40 | EPHA4 | 1.30997472 |
| 41 | CDK3 | 1.27515082 |
| 42 | DYRK2 | 1.26796900 |
| 43 | PAK3 | 1.23576572 |
| 44 | EIF2AK2 | 1.22922669 |
| 45 | MST4 | 1.19694217 |
| 46 | MAP2K7 | 1.17995803 |
| 47 | EEF2K | 1.15947583 |
| 48 | ERBB3 | 1.13846231 |
| 49 | PIK3CG | 1.12066565 |
| 50 | MAP3K10 | 1.11507146 |
| 51 | MKNK2 | 1.10228212 |
| 52 | EPHB1 | 1.09164303 |
| 53 | BLK | 1.07968334 |
| 54 | YES1 | 1.07354836 |
| 55 | MAP2K6 | 1.03644651 |
| 56 | CSK | 1.02509362 |
| 57 | INSRR | 1.02393155 |
| 58 | TRPM7 | 1.01615291 |
| 59 | NEK2 | 0.98098973 |
| 60 | MAP3K13 | 0.96325601 |
| 61 | IRAK2 | 0.96050589 |
| 62 | LCK | 0.94087021 |
| 63 | AKT3 | 0.93670433 |
| 64 | TGFBR1 | 0.92366610 |
| 65 | ADRBK1 | 0.92080365 |
| 66 | OBSCN | 0.91923112 |
| 67 | MARK2 | 0.89979138 |
| 68 | PRKCG | 0.89802201 |
| 69 | PKN1 | 0.87573481 |
| 70 | TIE1 | 0.86309172 |
| 71 | GRK1 | 0.82039243 |
| 72 | IRAK3 | 0.80164668 |
| 73 | LYN | 0.80048389 |
| 74 | MUSK | 0.79801786 |
| 75 | NLK | 0.79273446 |
| 76 | PHKG1 | 0.79091682 |
| 77 | PHKG2 | 0.79091682 |
| 78 | MAP3K4 | 0.78968047 |
| 79 | SYK | 0.78355390 |
| 80 | TBK1 | 0.78063439 |
| 81 | BCR | 0.75416492 |
| 82 | IRAK1 | 0.75113027 |
| 83 | IGF1R | 0.74284600 |
| 84 | BRD4 | 0.73947914 |
| 85 | SGK2 | 0.73278033 |
| 86 | MARK1 | 0.71945616 |
| 87 | CAMK1G | 0.71299383 |
| 88 | IKBKE | 0.70652908 |
| 89 | BMX | 0.69087047 |
| 90 | JAK2 | 0.68977050 |
| 91 | PIK3CA | 0.68051298 |
| 92 | BRSK2 | 0.67492368 |
| 93 | PNCK | 0.67289665 |
| 94 | PRKCQ | 0.66304030 |
| 95 | RPS6KA2 | 0.66266157 |
| 96 | SGK1 | 0.65751551 |
| 97 | BMPR2 | 0.65563134 |
| 98 | PRKCI | 0.64512323 |
| 99 | JAK1 | 0.64265863 |
| 100 | FGFR2 | 0.64033925 |
| 101 | TEC | 0.63667459 |
| 102 | CSNK1A1L | 0.59283406 |
| 103 | MYLK | 0.59251401 |
| 104 | FYN | 0.58338171 |
| 105 | CHUK | 0.57935123 |
| 106 | ITK | 0.57665449 |
| 107 | BTK | 0.57454160 |
| 108 | TYK2 | 0.56582125 |
| 109 | ZAK | 0.55500675 |
| 110 | CSNK1G1 | 0.55319643 |
| 111 | PRKAA2 | 0.54901982 |
| 112 | CLK1 | 0.54769803 |
| 113 | RPS6KA5 | 0.53946473 |
| 114 | VRK1 | 0.52925783 |
| 115 | FER | 0.52322705 |
| 116 | MAP3K5 | 0.52290710 |
| 117 | SIK1 | 0.52272860 |
| 118 | CAMK1 | 0.51769355 |
| 119 | DYRK3 | 0.51139711 |
| 120 | BCKDK | 0.51103265 |
| 121 | EIF2AK3 | 0.50323239 |
| 122 | PRKCE | 0.49285296 |
| 123 | CSNK1G2 | 0.48875451 |
| 124 | CSNK1G3 | 0.48157506 |
| 125 | STK38L | 0.48138385 |
| 126 | PRKCH | 0.48100648 |
| 127 | STK11 | 0.47580888 |
| 128 | PLK2 | 0.47346470 |
| 129 | MAPKAPK5 | 0.47000492 |
| 130 | SGK494 | 0.46915533 |
| 131 | SGK223 | 0.46915533 |
| 132 | WEE1 | 0.46641174 |
| 133 | ZAP70 | 0.45978477 |
| 134 | EGFR | 0.44206148 |
| 135 | PTK2B | 0.44045406 |
| 136 | CAMK1D | 0.43751556 |
| 137 | TGFBR2 | 0.43200691 |
| 138 | PRKACA | 0.42495511 |
| 139 | PTK2 | 0.41975258 |
| 140 | NTRK2 | 0.41963371 |
| 141 | TAF1 | 0.41714303 |
| 142 | CAMK4 | 0.39768036 |
| 143 | SGK3 | 0.39296966 |
| 144 | INSR | 0.39235932 |
| 145 | CSNK1A1 | 0.38738525 |
| 146 | MAPKAPK3 | 0.38725908 |
| 147 | CAMKK1 | 0.38389445 |
| 148 | CAMK2A | 0.37864931 |
| 149 | MAP3K12 | 0.37690864 |
| 150 | TYRO3 | 0.36380684 |
| 151 | MAPK15 | 0.35725522 |
| 152 | SIK3 | 0.35711789 |
| 153 | MAPK12 | 0.35294885 |
| 154 | STK3 | 0.35268037 |
| 155 | PRKCA | 0.33537727 |
| 156 | TAOK2 | 0.33065264 |
| 157 | MATK | 0.32168474 |
| 158 | MAP2K1 | 0.30653328 |
| 159 | MKNK1 | 0.30434576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ABC transporters_Homo sapiens_hsa02010 | 3.43550893 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.80757523 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.69811013 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.61523136 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.61299287 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54982264 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.38555397 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20403713 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.18390021 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.11197150 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07738584 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00393383 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98544537 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97849144 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 1.92549249 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91622515 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78694241 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77473816 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.75261697 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.74239577 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70525647 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66898627 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.64654849 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63785203 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.59109951 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58057292 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.50935227 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49688647 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.49277050 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.49112939 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.46796270 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.46783254 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43880816 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.43656087 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43419937 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42546236 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.41690671 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41190461 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39168882 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38604267 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.37653342 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.30735116 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30669356 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28444688 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.26171512 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25851777 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22426110 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22418088 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20997410 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19283082 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18303668 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17814241 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.16503121 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13707633 |
| 55 | Measles_Homo sapiens_hsa05162 | 1.11916862 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09518951 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09388375 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09312021 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08900295 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08218943 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07485424 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.06806053 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.06804548 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06462767 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04475585 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04018812 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02991515 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01564555 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00700642 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 1.00491147 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.00455279 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99946756 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99073772 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.98371585 |
| 75 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98259408 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.98185704 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97937532 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97936063 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97082315 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97078213 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97047870 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95915009 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.94815347 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94181683 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93424469 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92094789 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92051871 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.90994681 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89090100 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88878380 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87678042 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86556969 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86435463 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86031365 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.85801336 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.85346114 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85275660 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83996565 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81410512 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.80568820 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80380732 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79551146 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79525783 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79359501 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.78826329 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.78731398 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.78458339 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76955564 |
| 109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76519524 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75596696 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75068072 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72187359 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71902031 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71544431 |
| 115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71320730 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71176671 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69654483 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.69587227 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69277207 |
| 120 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69154024 |
| 121 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67903098 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67202009 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66995606 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66935290 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.66844324 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66225455 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65111573 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65097048 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64944417 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.64751933 |
| 131 | Legionellosis_Homo sapiens_hsa05134 | 0.64325339 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.63130781 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.62572310 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60347699 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59830117 |
| 136 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59523650 |
| 137 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59385228 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.59290686 |
| 139 | Salivary secretion_Homo sapiens_hsa04970 | 0.58515897 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.58092953 |
| 141 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55986195 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.54736245 |
| 143 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54590997 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53942299 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53881970 |
| 146 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53190685 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52881626 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52347780 |
| 149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51661568 |
| 150 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51456733 |
| 151 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47777812 |
| 152 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46579010 |
| 153 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46282814 |
| 154 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46132626 |
| 155 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40230699 |
| 156 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38408746 |
| 157 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.38026959 |
| 158 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36736244 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35763738 |
| 160 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35184982 |
| 161 | Purine metabolism_Homo sapiens_hsa00230 | 0.34542412 |
| 162 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32886097 |
| 163 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31401030 |

